MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Heavy metals"

  • 2026 International Congress

    What Non-Genetic Parkinson’s Disease Risk Factors are Africans Exposed To? A Scoping Review

    J. Lee, R. Mwezi, R. Morton, N. Fothergill-Misbah, C. Dotchin, R. Walker (United Kingdom)

    Objective: We set out to catalogue the risk factors patients with Parkinson’s Disease (PD) in Africa are exposed to. Background: Parkinson's disease (PD) is recognized…
  • 2026 International Congress

    Serum Zinc Reduction During Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion in Parkinson’s Disease

    T. Utsunomiya, K. Matsuura, K. Miyashita, A. Shindo (Tsu, Mie, Japan)

    Objective: To investigate whether continuous subcutaneous foslevodopa/foscarbidopa infusion reduces serum zinc levels in patients with Parkinson’s disease. Background: Reduced serum zinc levels in Parkinson’s disease…
  • 2026 International Congress

    Association of Riverine Heavy Metal Contamination with Parkinson’s Disease Risk in Rural Pune: A Population-Based Case-Control Study

    A. Gangadhar, Y. Dayma (Pune, India)

    Objective: To evaluate the epidemiological and biochemical associations between chronic exposure to heavy metal-polluted river water and the risk of developing Parkinson’s disease (PD) in…
  • 2024 International Congress

    Exploring Quantitative Susceptibility Mapping in Wilson’s Disease- A Prospective Cohort Study

    A. Aliyar, D. Radhakrishnan, A. Garg, A. Srivastava, R. Rajan, A. Pandit, A. Das, A. Agarwal (Delhi, India)

    Objective: To describe the quantitative magnetic susceptibility(QSM) in Wilson’s disease (WD) and healthy controls Background: Quantitative susceptibility mapping (QSM) is a post processing technique that…
  • 2024 International Congress

    Laboratory changes of the liver function in the patients with Wilson’s disease

    I. Voloshyn-Haponov, A. Teslenko, L. Cherkashyna, O. Korzh (Kharkiv, Ukraine)

    Objective: Wilson's disease (WD) is a chronic progressive neurodegenerative disease with a genetically determined disorder of copper metabolism due to mutations in the ATP7B gene,…
  • 2024 International Congress

    Delayed movement disorders after usage of desomorphine-“crocodile”. Clinical case.

    G. Ilina, D. Khasanova, Z. Zalyalova, A. Katok (Kazan, Russian Federation)

    Objective: To study the clinical and neuroimaging features of a patient with a long-term use (more than 10 years) of desomorphine in the anamnesis. Background:…
  • 2023 International Congress

    Serum Zinc Deficiency could be associated with dementia conversion in Parkinson’s disease

    W. Jang (Gangneung, Republic of Korea)

    Objective: To investigate the role of depletion or excess of various heavy metals on clinical characteristics of Parkinson's disease (PD) developing PD dementia in drug-naïve…
  • 2023 International Congress

    Evaluation of blood heavy metal concentrations in patients with essential tremor

    I. Korucu, A. Aksoy Gündoğdu, N. Bahtiyar (Tekirdag, Turkey)

    Objective: In this study, we aimed to investigate the relationship between tremor characteristics, neuropsychiatric status and blood heavy metal levels of essential tremor (ET) patients.…
  • 2022 International Congress

    An Ecologic Study of Aqueous Lead Exposure and Parkinson’s Disease

    G. Schwartz, M. Williamson (Grand Forks, USA)

    Objective: Examine the potential role of lead in water as a risk factor for PD. Background: Studying disease rates in different locations is an established…
  • 2022 International Congress

    Synaptic Zn2+ Contribution to Parkinson’s Disease Pathophysiology: Pharmacological & Genetic Studies in Preclinical Mouse Models

    AM. Ouagazzal, J. Sikora (Marseille, France)

    Objective: The potential involvement of synaptic Zn2+ in development of Parkinson’s disease (PD) motor symptoms and dopaminergic neurodegeneration was investigated. Background: The progressive degeneration of…
  • 1
  • 2
  • 3
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley